Literature DB >> 17447509

Early recurrence of completely resected N2-positive non-small-cell lung cancer.

Takuma Tsukioka1, Noritoshi Nishiyama, Takashi Iwata, Nobuhiro Izumi, Shinjiro Mizuguchi, Ryuhei Morita, Kiyotoshi Inoue, Shigefumi Suehiro.   

Abstract

OBJECTIVE: Postoperative early recurrence, defined as recurrence within 1 year postoperatively, is often experienced with completely resected N2 disease. In this study, we evaluated the risk factors for early recurrence with completely resected N2 disease.
METHODS: . Potential risk factors for postoperative early recurrence were evaluated in 75 patients with N2 disease who underwent complete resection without any preoperative therapy. Prognostic significance was determined by univariate and multivariate analyses.
RESULTS: The median follow-up period was 24 months, and the 5-year survival rate was 23%. Thirty-nine patients developed postoperative early recurrence. The 1-, 3-, and 5-year survival rates of patients with early recurrence were 64%, 10%, and 5%, respectively, and 100%, 51%, and 34%, respectively (p < 0.001). Multistation N1 metastasis was a risk factor for postoperative early recurrence by univariate analysis and an independent risk factor by multivariate analysis.
CONCLUSIONS: Early recurrence is a significant poor prognostic factor for completely resected N2 disease. It is suggested that the number of N1 stations with metastasis is a risk factor for early recurrence and a poor prognostic factor in N2 disease.

Entities:  

Mesh:

Year:  2007        PMID: 17447509     DOI: 10.1007/s11748-006-0082-6

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  16 in total

1.  Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer.

Authors:  Yong Soo Choi; Young Mog Shim; Jhingook Kim; Kwhanmien Kim
Journal:  Eur J Cardiothorac Surg       Date:  2002-11       Impact factor: 4.191

2.  Postrecurrent survival of patients with non-small-cell lung cancer undergoing a complete resection.

Authors:  Y Ichinose; T Yano; H Yokoyama; T Inoue; H Asoh; K Tayama; N Takanashi
Journal:  J Thorac Cardiovasc Surg       Date:  1994-07       Impact factor: 5.209

3.  Lymph node mapping and curability at various levels of metastasis in resected lung cancer.

Authors:  T Naruke; K Suemasu; S Ishikawa
Journal:  J Thorac Cardiovasc Surg       Date:  1978-12       Impact factor: 5.209

4.  Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.

Authors:  K Furuse; M Fukuoka; M Kawahara; H Nishikawa; Y Takada; S Kudoh; N Katagami; Y Ariyoshi
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

Review 5.  The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis.

Authors:  Roy M Bremnes; Robert Veve; Fred R Hirsch; Wilbur A Franklin
Journal:  Lung Cancer       Date:  2002-05       Impact factor: 5.705

6.  Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.

Authors:  Shun-ichi Watanabe; Hisao Asamura; Kenji Suzuki; Ryosuke Tsuchiya
Journal:  Ann Thorac Surg       Date:  2005-05       Impact factor: 4.330

7.  Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.

Authors:  F Andre; D Grunenwald; J P Pignon; A Dujon; J L Pujol; P Y Brichon; L Brouchet; E Quoix; V Westeel; T Le Chevalier
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

8.  The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.

Authors:  Robert James Cerfolio; Buddhiwardhani Ojha; Ayesha S Bryant; Vanguru Raghuveer; James M Mountz; Alfred A Bartolucci
Journal:  Ann Thorac Surg       Date:  2004-09       Impact factor: 4.330

9.  A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304).

Authors:  Hirohito Tada; Ryosuke Tsuchiya; Yukito Ichinose; Teruaki Koike; Nobuhiro Nishizawa; Kanji Nagai; Harubumi Kato
Journal:  Lung Cancer       Date:  2004-02       Impact factor: 5.705

10.  Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung.

Authors:  Adnan Sayar; Akif Turna; Ali Kiliçgün; Okan Solak; Nur Urer; Atilla Gürses
Journal:  Eur J Cardiothorac Surg       Date:  2004-03       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.